Results 241 to 250 of about 58,205 (308)
ABSTRACT Objectives Considering the high frequency of intravesical recurrence in bladder urothelial carcinoma (UBC), accurate non‐invasive biomarkers for recurrence prediction are needed for better management after transurethral surgery. This pilot study examined the usefulness of urine DNA for detecting and predicting intravesical recurrence in UBC ...
Masashi Shiozaki +6 more
wiley +1 more source
Improving radiomics-based isocitrate dehydrogenase 1 prediction in glioma patients using semi-supervised machine learning models. [PDF]
Ahmadzadeh AM +5 more
europepmc +1 more source
ABSTRACT Inflammatory biomarkers, such as leukocyte ratios, have emerged as promising tools for diagnosing and prognosticating brain gliomas. This study systematically reviewed and analysed the diagnostic and prognostic relevance of peripheral blood leukocyte ratios in glioma.
Fatemeh Hasani +12 more
wiley +1 more source
Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? [PDF]
Barsch M +3 more
europepmc +1 more source
ABSTRACT Acute myeloid leukaemia (AML) is a genetically heterogeneous malignancy associated with poor prognosis and limited treatment options. To identify molecular programs conserved across AML subtypes and perturbations, we analysed three RNA sequencing datasets that captured venetoclax treatment under metabolic stress and the knockdown of chromatin ...
Muteb Muyey Daniel, Gradel Holel Andwey
wiley +1 more source
Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors. [PDF]
Nikitsenka K +9 more
europepmc +1 more source
Oxidative Phosphorylation in Silent Pituitary Adenomas: A Multiomics Perspective
Although the World Health Organization has clearly defined silent pituitary adenomas (SPAs) and functional adenomas (non‐SPAs), the detailed biological mechanisms remain unclear. This study conducted a comprehensive analysis of clinical, genomic, transcriptomic, and proteomic differences between SPA and non‐SPA.
Yuan Chen +5 more
wiley +1 more source

